Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.55 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.50 |
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.44 |
| ▸ | GABRP | O00591 | 1/20 | 0.44 |
| ▸ | GABRD | O14764 | 1/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.44 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.44 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.44 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.44 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.44 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.44 |
| ▸ | GABRE | P78334 | 1/20 | 0.44 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.44 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.44 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.44 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13100683 | 0.81 | GPR3 (0.57) | GPR3PABPC1KIF11GABRPGABRD | |
| SCHEMBL23371952 | 0.77 | GPR3 (0.52) | GPR3PABPC1KIF11GABRPGABRD | |
| SCHEMBL3423941 | 0.75 | GPR3 (0.80) | GPR3PABPC1KIF11KDM4EALDH1A1 | |
| SCHEMBL3880532 | 0.74 | PABPC1 (0.70) | GPR3PABPC1KIF11LIMK1KDM4E | |
| SCHEMBL3875050 | 0.74 | GPR3 (0.64) | GPR3PABPC1KIF11KDM4EALDH1A1 | |
| SCHEMBL29461528 | 0.74 | GPR3 (1.00) | GPR3PABPC1KIF11KDM4EALDH1A1 | |
| SCHEMBL29321 | 0.74 | GPR3 (1.00) | GPR3PABPC1KIF11KDM4EALDH1A1 | |
| SCHEMBL9889048 | 0.73 | GPR3 (0.76) | GPR3PABPC1KIF11KDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL31174327 | 0.72 | GPR3 (0.94) | GPR3PABPC1KIF11KDM4EALDH1A1 | |
| SCHEMBL18381839 | 0.72 | GPR3 (0.94) | GPR3PABPC1KIF11KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3893941-A1 | MICROBIOTA METABOLITES THAT SHAPE HOST PHYSIOLOGY | Yale University (US) | 2021-10-20 | — | — | EP | claimed |
| WO-2020123376-A1 | MICROBIOTA METABOLITES THAT SHAPE HOST PHYSIOLOGY | YALE UNIVERSITY (US) | 2020-06-18 | — | — | WO | claimed |
| EP-3893941-A1 | MICROBIOTA METABOLITES THAT SHAPE HOST PHYSIOLOGY | Yale University (US) | 2021-10-20 | — | — | EP | disclosed |
| WO-2020123376-A1 | MICROBIOTA METABOLITES THAT SHAPE HOST PHYSIOLOGY | YALE UNIVERSITY (US) | 2020-06-18 | — | — | WO | disclosed |
| EP-3328498-A1 | HERBAL COMBINATIONS FOR TREATING PSORIASIS | Sirbal Ltd. (CY) | 2018-06-06 | — | — | EP | disclosed |
| WO-2017019651-A1 | HERBAL COMBINATIONS FOR TREATING PSORIASIS | SIRBAL LTD. (CY) | 2017-02-02 | — | — | WO | disclosed |
| WO-2017003430-A1 | MOLECULAR AND HERBAL COMBINATIONS WITH METHOTREXATE FOR TREATING DISEASES AND INFLAMMATORY AILMENTS | SIRBA LTD. (CY) | 2017-01-05 | — | — | WO | disclosed |
| EP-3076984-A1 | HERBAL COMBINATIONS FOR TREATMENT OF A SKIN CONDITION | Sirbal Ltd. (CY) | 2016-10-12 | — | — | EP | disclosed |
| WO-2015082950-A1 | HERBAL COMBINATIONS FOR TREATMENT OF A SKIN CONDITION | SIRBAL LTD. (CY) | 2015-06-11 | — | — | WO | disclosed |
| EP-1954838-A2 | CODED MOLECULES FOR DETECTING TARGET ANALYTES | Applera Corporation (US) | 2008-08-13 | — | — | EP | disclosed |
| WO-2007120265-A2 | CODED MOLECULES FOR DETECTING TARGET ANALYTES | APPLERA CORPORATION (US) | 2007-10-25 | — | — | WO | disclosed |
| WO-2004064725-A2 | ORAL COMPOSITIONS AND METHODS FOR TREATMENT OF ADVERSE EFFECTS OR RADIATION | THE QUIGLEY CORPORATION (US) | 2004-08-05 | — | — | WO | disclosed |
| EP-1409681-A2 | PROTEINS AND NUCLEIC ACIDS ENCODING SAME | Curagen Corporation (US) | 2004-04-21 | — | — | EP | disclosed |
| WO-2003051287-A2 | TOPICAL COMPOSITIONS AND METHODS FOR TREATMENT OF ADVERSE EFFECTS OF IONIZING RADIATION | THE QUIGLEY CORPORATION (US) | 2003-06-26 | — | — | WO | disclosed |
| WO-2003039452-A2 | NUTRITIONAL SUPPLEMENTS AND METHODS FOR PREVENTION, REDUCTION AND TREATMENT OF RADIATION INJURY | THE QUIGLEY CORPORATION (US) | 2003-05-15 | — | — | WO | disclosed |
| EP-1296714-A2 | METHODS FOR ENHANCING ANTIBODY-INDUCED CELL LYSIS AND TREATING CANCER | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2003-04-02 | — | — | EP | disclosed |
| WO-2002068649-A2 | PROTEINS AND NUCLEIC ACIDS ENCODING SAME | CURAGEN CORPORATION (US) | 2002-09-06 | — | — | WO | disclosed |
| WO-2001097843-A2 | METHODS FOR ENHANCING ANTIBODY-INDUCED CELL LYSIS AND TREATING CANCER | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2001-12-27 | — | — | WO | disclosed |
| EP-0090610-A2 | A method for treatment of mutagens | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-10-05 | — | — | EP | disclosed |
| EP-0040641-A1 | PROCESS FOR ISOLATING AND PURIFYING A FRACTION CAPABLE OF INHIBITING MUTAGENICITY OF A MUTAGENIC MATERIAL FROM BURDOCK JUICE | KANEBO, LTD. (JP) | 1981-12-02 | — | — | EP | disclosed |